Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

Opioid overdose deaths have decreased for 12 months, with 70,655 predicted deaths through June 2024, down from 86,401 in June ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

HUNTINGTON, W.Va. (WSAZ) - The U.S. Food and Drug Administration has authorized the first over-the-counter test that can ...

Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered ...

Part 3 of this series for Global Biosimilars Week, penned by Dracey Poore, director of biosimilars at Cardinal Health, ...

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...

Clinical development and trial testing of vesleteplirsen (SRP-5051) for Duchenne muscular dystrophy (DMD) was stopped, with ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

The day after the election, some celebrated Trump's win and RFK Jr.'s potential role as a public health decision-maker. Why?

The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...